Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. - Wikidata - wikimedia - TriplyDB

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

http://www.wikidata.org/entity/Q30583848

about

Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection.Imaging Nanotherapeutics in Inflamed Vasculature by Intravital Microscopy Synthetic Nanoparticles for Vaccines and Immunotherapy Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activity Cell membrane-formed nanovesicles for disease-targeted delivery.De novo chemoattractants form supramolecular hydrogels for immunomodulating neutrophils in vivo.Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.Neutrophils in the Tumor Microenvironment.Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases.Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.Neutrophils as protagonists and targets in chronic inflammation.Immunomodulatory Nanomedicine.Imaging of anticancer drug action in single cells.Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery.Free and nanoencapsulated vitamin D3 : effects on E-NTPDase and E-ADA activities in an animal model with induced arthritis.Titanium dioxide nanoparticles prime a specific activation state of macrophages.Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy.Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy.Targeted antithrombotic protein micelles.Caveolae-mediated Delivery of Therapeutic Nanoparticles across Blood-endothelial Barrier.Cell membrane coated nanoparticles: next-generation therapeutics.Immunoengineering with biomaterials for enhanced cancer immunotherapy.Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration.Longitudinal monitoring of skin accumulation of nanocarriers and biologicals with fiber optic near infrared fluorescence spectroscopy (FONIRS).Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.Neutrophil-mediated delivery of nanotherapeutics across blood vessel barrier.High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy.Neutrophils, a candidate biomarker and target for radiation therapy?Novel nanoparticulate drug delivery systems.Recent advances in nanomedicine for sepsis treatment.Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer.CD177-mediated nanoparticle targeting of human and mouse neutrophils

P2860

Q27341910-98071C42-E370-49F7-AB36-B944AEF59588 Q28080268-E24E6114-2302-406F-B0EC-EBA3EE11E457 Q28085375-1441E17F-ADBC-4AEB-B56F-5C90240D7A36 Q28396375-5ECF528D-2C77-42F9-B034-D7F15E63AEE7 Q28468632-83CB8C7B-A6FF-44C9-B1DB-5DD2D442513E Q30708969-7674D3ED-BDFB-4681-8F5E-00CDA841C8C7 Q34764456-06B6C242-C058-4EEA-B8DA-58E82355E863 Q36848196-9B0BE215-F571-4A98-BFEA-F3D3AA700225 Q38678088-9023DF45-220F-482B-88BD-CD7C09291157 Q38856246-02E57278-9C32-48B4-B0DA-1BF88397F8F0 Q38965212-59CFB7E2-D886-4E08-B56F-D4293075E9EE Q39159035-E1A4F728-5B59-4864-8CA5-53AB0CB83013 Q39175804-3C8E23C3-6CE9-4FB7-B1A0-8B25218F0B25 Q39224331-7EA11F42-3720-4923-BF65-6C8E790D3CF6 Q39392711-41A54B49-2184-4125-9DE4-B362FD83F2D0 Q39458951-C2218DF1-3167-48D8-8DFB-A861C5CDB99D Q39832462-A05F113B-2472-477E-8F82-12B36D5A4C89 Q40150495-4DC6CB9B-DAA7-46D3-8ADD-9149ED65665C Q41421790-96E682DC-F022-4DCB-9374-C6FA3D4B1CF8 Q41430285-6340EC12-7F57-4D4E-B52C-3392589905DE Q42617570-701C64BD-1AB2-47EC-A534-97CC450D1F41 Q42635523-63E7E3D7-A3CF-4799-95C9-704661C1D23C Q47613637-43FBFBD1-9B7A-41A9-988D-1944BDB17FAC Q47732542-1AE92AEB-CF94-4FFE-828D-81B13B0B68A4 Q48145301-CCD0E4F9-1670-45BC-BB06-AFC865F5F5AC Q49179778-D406DAF4-7731-4F0E-9A07-94B76208C9CC Q49788067-465E4FDE-6C4F-4D33-8C00-D7C61C982706 Q50026117-BB1A0A22-F324-45AB-AE86-67A71C785441 Q50644362-2665AFF3-A5BC-40B8-992E-D01C49778B1A Q51802063-3ABE9D3A-C909-4896-95A7-84F8469AAA23 Q53487380-9BB01EB2-7E10-4BFF-8373-E54224C0ED32 Q54222088-B5584BBF-3352-47C9-A184-FED22B11F8D2 Q55083592-0A168D3B-A829-404E-ACD6-285EBA642BAC Q56888986-10DBF43F-79FD-4984-81C1-73169254D457

P2860

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

http://www.wikidata.org/entity/Q30583848

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

@ast

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

@en

type

label

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

@ast

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

@en

prefLabel

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

@ast

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

@en

P1433

Q30583848-548DA0C6-16E1-4C7E-A3E6-092B7A9D6C2C

P1476

Q30583848-51F06DD5-3BE7-4EF0-A178-133ADA7450CE

P2093

Q30583848-10A6C25C-1754-4577-85CF-B8B0DD0DEA35

Q30583848-58B8F2C3-79A5-49A1-98B5-34D973A1762D

Q30583848-752AC807-F0A0-4E04-8FCB-08DADFFC2B2A

Q30583848-B5629B6A-333A-46E7-98F6-C8574B673C57

P2860

Q30583848-00F7F990-A917-47CC-B217-EFA790F2BDA6

Q30583848-0CF72FC5-6F1B-467F-A575-CBA2A84EB29D

Q30583848-1A53BFDD-464F-49D4-AEB8-B39F50F0F568

Q30583848-25861924-846C-415C-9C52-2615AD94148F

Q30583848-3DE6C8B5-236F-4624-B0A8-A0E94DA47AE5

Q30583848-4F0D6D40-3986-4323-8488-D46921342B59

Q30583848-5339A887-0E65-4E79-93F7-E4639836424A

Q30583848-63EE4117-864D-46A9-9D8F-69DA4D8CC10B

Q30583848-6A63F69B-7AAA-4DFB-AD36-00D20A612D31

Q30583848-79CCD886-567B-44C8-847A-4EEA23F51F0D

P2888

Q30583848-31BDD4A9-E0DF-4F60-9BD6-02FD7FA71959

P304

Q30583848-F8CD7C72-5E1A-4F6F-9AED-0B9BE63578E8

P31

Q30583848-7CDA1B2A-FD77-4C18-93DD-F17CE829DC70

P356

Q30583848-5F1F870E-E16E-41A7-BE48-B3AE6A899992

P407

Q30583848-CAD51C5D-EAEB-4B28-B221-9CD374D4F9B2

P433

Q30583848-8CC3EE5F-3C04-498C-923E-4D73EDC173C9

P478

Q30583848-874C83E1-8C42-4116-A2C3-3F93E9AFD032

P577

Q30583848-4ABC37F2-59B7-4A22-8038-0CBCAE06CAAF

P5875

Q30583848-2056771A-A554-4F95-92E6-B7170881CE5C

P6179

Q30583848-53007174-7C27-4EB6-AA42-7DF2B0C8858D

P698

Q30583848-E859BFEA-BC08-49BB-8CFA-1B0476A3CFE5

P921

Q30583848-28BBE264-887B-44DB-B63A-EEF4C872A414

Q30583848-4496F1AD-A906-4F52-A22E-7CAB9C63D2DD

P932

Q30583848-F7FE4759-AD21-4EBC-B718-34400EF76145

P356

P1433

Nature Nanotechnology

P1476

Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils.

@en

P2093

Asrar B Malik

http://www.w3.org/2001/XMLSchema#string

Jaehyung Cho

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Zhenjia Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-inflammatory therapy in chronic disease: challenges and opportunities

The molecular dissection of Fc gamma receptor mediated phagocytosis

Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1.

Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury

LFA-1 and Mac-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ.

Extracellular protein disulfide isomerase regulates ligand-binding activity of αMβ2 integrin and neutrophil recruitment during vascular inflammation

Piceatannol (3,4,3',5'-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor.

The acute respiratory distress syndrome: pathogenesis and treatment

Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae

Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms.

P2888

P304

204-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NNANO.2014.17

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260374463

http://www.w3.org/2001/XMLSchema#string

P6179

1001059079

http://www.w3.org/2001/XMLSchema#string

P698

24561355

http://www.w3.org/2001/XMLSchema#string

P921

P932

4100792

http://www.w3.org/2001/XMLSchema#string